Stock UniverseDerived research view · source repositories remain read-only

Beta Bionics, Inc. (BBNX)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Speculative
Selection Score
27.77
Global Rank
2367
Market Cap
560.55M
Latest Close
13.89
RS Composite
-9.99% · G#2090

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
31.41%
3M
30.91%
6M
-54.31%
1Y
-28.59%
3Y
-41.22%
5Y
-41.22%
10Y
-41.22%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.01M · 30-day average: 756.92K · Max drawdown over stored range: -72.30%

Research Snapshot

Relative Strength vs SPX

RS Composite-9.99%
20D RS31.65%
60D RS18.81%
120D RS-59.61%
Global RS Rank2090 · 37.70% percentile
Watch+Speculative RS Rank1307 · 37.67% percentile
Group ScopeWatch+Speculative
Primary RS Rank72 · 49.30% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank117 / 246
Primary Percentile52.85
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for BBNX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2022FY 2023FY 2024FY 2025
Revenue0.17911.99565.124100.251
Revenue Growth (YoY)3000%6601.117%442.926%53.939%
Gross Profit0.1796.30835.88855.537
Operating Income-64.744-35.85-45.251-71.681
Free Cash Flow-60.98-32.847-51.6680
Free Cash Flow Per Share-12.202-6.193-8.11730
EPS (Diluted) GAAP-12.956616-8.314786-8.602584-1.806111
EPS Growth
EPS Non-GAAP
Gross Margin100%52.589%55.107%55.398%
Operating Margin-36169.832%-298.875%-69.484%-71.502%
Profit Margin-36173.743%-367.645%-84.08%-73.017%
Free Cash Flow Margin-34067.039%-273.839%-79.338%3000%
Shares Outstanding (Diluted)4.99755.30376.365140.5291
Shares Change (YoY)3000%6.126%20.012%536.742%

SEC Quarterly Fundamentals

No processed quarterly rows for BBNX.